Journal
STEROIDS
Volume 114, Issue -, Pages 41-47Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2016.06.007
Keywords
Estrogen receptor; Kinase signaling; Breast cancer; Tamoxifen resistance
Funding
- National Institute of Food and Agriculture, U.S. Department of Agriculture [ILLU-698-909]
Ask authors/readers for more resources
Estrogens regulate function of reproductive and non-reproductive tissues in healthy and diseased states including breast cancer. They mainly work through estrogen receptor alpha (ER alpha) and/or estrogen receptor beta (ER beta). There are various ER alpha targeting agents that have been used for treatment of ER (+) breast tumors. The impact of direct nuclear activity of ER is very well characterized in ER (+) breast cancers and development and progression of endocrine resistance. Recent studies also suggested important roles for extranuclear-initiated ER alpha pathways, which would decrease the potency and efficiency of ER alpha targeting agents. In this mini-review, we will discuss the role of nuclear and extra-nuclear ER signaling and how they relate to therapy resistance in breast cancer. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available